Imaging study tests if new drug can remodel damaged lung arteries
NCT ID NCT06907693
Summary
This study is testing whether an investigational drug called CS1 can improve the structure and function of small blood vessels in the lungs of people with pulmonary arterial hypertension (PAH). It uses a special, non-invasive imaging scan to see if long-term use of CS1 leads to positive changes in these vessels over 12 months. The goal is to understand if CS1 could become a new treatment option to control this serious lung and heart condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prisma Health
Greenville, South Carolina, 29605, United States
Conditions
Explore the condition pages connected to this study.